Discovery of novel benzimidazolones as potent non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains
- 1 April 2007
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (7), 1956-1960
- https://doi.org/10.1016/j.bmcl.2007.01.025
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Crystallography and the design of anti-AIDS drugs: conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitorsProgress in Biophysics and Molecular Biology, 2005
- Computational Strategies in Discovering Novel Non-nucleoside Inhibitors of HIV-1 RTJournal of Medicinal Chemistry, 2005
- Current Status of the Non-nucleoside Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Type 1Current Topics in Medicinal Chemistry, 2004
- Novel Indolyl Aryl Sulfones Active against HIV-1 Carrying NNRTI Resistance Mutations: Synthesis and SAR StudiesJournal of Medicinal Chemistry, 2003
- Design, Synthesis, Structure−Activity Relationships, and Molecular Modeling Studies of 2,3-Diaryl-1,3-thiazolidin-4-ones as Potent Anti-HIV AgentsJournal of Medicinal Chemistry, 2002
- 2-Amino-6-arylsulfonylbenzonitriles as Non-nucleoside Reverse Transcriptase Inhibitors of HIV-1Journal of Medicinal Chemistry, 2001
- Structural Basis for the Resilience of Efavirenz (DMP-266) to Drug Resistance Mutations in HIV-1 Reverse TranscriptaseStructure, 2000
- Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy functionJournal of Computational Chemistry, 1998
- LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions"Protein Engineering, Design and Selection", 1995
- 5-Chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptaseJournal of Medicinal Chemistry, 1993